Literature DB >> 16357738

Reversible posterior leukoencephalopathy syndrome in systemic lupus erythematosus with thrombocytopenia treated with cyclosporine.

Ki Chul Shin1, Hyo Jin Choi, Yeong Deok Bae, Jung Chan Lee, Eun Bong Lee, Yeong Wook Song.   

Abstract

Thrombocytopenia is one of the common manifestations of systemic lupus erythematosus (SLE). Its treatment consists of corticosteroids and/or other immunosuppressive drug such as azathioprine, vincristine, cyclosporine, and mycophenolate mofetil. Common adverse reactions of immunosuppressive treatment are infections, hematologic and liver function abnormalities, but neurologic complications may also be seen. Reversible posterior leukoencephalopathy syndrome (RPLS) is a syndrome manifested by headache, nausea, vomiting, seizures, cortical blindness, and visual disturbances. Neuroimaging shows bilateral subcortical and cortical edema with prominent posterior distribution. Moreover, treatment with immunosuppressive drugs such as cyclosporine, cisplatin, tacrolimus, and interferon-alpha can induce a condition resembling RPLS. We report a case of a young woman with SLE and thrombocytopenia, who developed severe perspiration, headache, and seizure after receiving cyclosporine. A brain magnetic resonance image showed multiple high signal intensities on T2-weighted images predominantly located at the parietooccipital lobe. The patient recovered completely clinically and radiologically after discontinuing cyclosporine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16357738     DOI: 10.1097/01.rhu.0000164825.63063.43

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  7 in total

Review 1.  Rheumatologic diseases and posterior reversible encephalopathy syndrome: two case reports and review of the literature.

Authors:  Anmol Dhillon; Celso Velazquez; Chokkalingam Siva
Journal:  Rheumatol Int       Date:  2012-07-24       Impact factor: 2.631

2.  Posterior reversible encephalopathy syndrome (PRES) attributed to mycophenolate mofetil during the management of SLE: a case report and review.

Authors:  Lei Zhang; Jian Xu
Journal:  Am J Clin Exp Immunol       Date:  2018-02-05

3.  A Rare Presentation of Lupus Nephritis Flare up with Posterior Reversible Leucoencephalopathy.

Authors:  S Hima Mani; S M Shivaprasad; L Umesh
Journal:  J Clin Diagn Res       Date:  2016-01-01

Review 4.  Eosinophilic granulomatosis with polyangiitis (EGPA) and PRES: a case-based review of literature in ANCA-associated vasculitides.

Authors:  A M Marra; G Barilaro; V Villella; M Granata
Journal:  Rheumatol Int       Date:  2015-04-03       Impact factor: 2.631

5.  Lysergic acid amide-induced posterior reversible encephalopathy syndrome with status epilepticus.

Authors:  Stephane Legriel; Fabrice Bruneel; Odile Spreux-Varoquaux; Aurelie Birenbaum; Marie Laure Chadenat; François Mignon; Nathalie Abbosh; Matthieu Henry-Lagarrigue; Laure Revault D'Allonnes; Pierre Guezennec; Gilles Troche; Jean Pierre Bedos
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

6.  Posterior Reversible Encephalopathy Syndrome as a Postpartum Complication.

Authors:  Samra Kadić-Vukas; Mirsada Hodžić; Lejla Tandir-Lihić; Lejla Hrvat; Azra Kožo-Kajmaković; Nina Kuzmanović; Haris Vukas
Journal:  Open Access Maced J Med Sci       Date:  2018-05-14

7.  Posterior reversible encephalopathy syndrome could be an underestimated variant of "reversible neurological deficits" in Systemic Lupus Erythematosus.

Authors:  Bin Liu; Xuan Zhang; Feng-Chun Zhang; Yuan Yao; Ri-Zhi Zhou; Miao-Miao Xin; Li-Qin Wang
Journal:  BMC Neurol       Date:  2012-12-05       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.